Toni Whistler work email
- Valid
- Valid
Toni Whistler personal email
Toni Whistler phone numbers
With over two decades in public health, I have dedicated my career to strengthening laboratory systems, advancing diagnostic capabilities, and shaping policy across a global landscape. My journey began with a Ph.D. in Medical Virology, which laid the foundation for my expertise in infectious disease control and molecular diagnostics. From there, I embarked on a path that would take me through multiple roles with the U.S. Centers for Disease Control and Prevention (CDC), where I worked closely with partners across Africa, Asia, and Europe.Throughout my career, I have been driven by a commitment to improving public health outcomes in low- and middle-income countries (LMICs). As a Health Scientist at the CDC, I led initiatives in Vietnam, Tanzania, Kazakhstan, Ghana, and beyond, integrating advanced molecular diagnostic technologies within local health systems. Notably, my leadership during the COVID-19 pandemic enabled international SARS-CoV-2 genome sequencing projects, enhancing global tracking and response capabilities. My work has contributed to the development of country-specific pandemic preparedness strategies and diagnostic tools, equipping LMICs to detect and respond to emerging threats.Serving as the CDC’s laboratory advisor to The Global Fund, I played a key role in expanding services beyond AIDS, Tuberculosis, and Malaria to include broader pandemic preparedness, working alongside WHO and Africa CDC to integrate genomic surveillance and laboratory strengthening frameworks. My collaborations led to critical policy documents and tools, such as the Genomics Costing Tool, to empower LMICs with cost-effective solutions for laboratory implementation.In my roles as a program director and consultant, I have pioneered initiatives from biosafety protocols to health system resilience frameworks, developing comprehensive policies that balance international standards with localized needs. My work with local Ministries of Health has not only strengthened public health infrastructure but has also fostered capacity-building, mentoring local scientists and health officials and enabling sustainable development in their communities.Today, I bring this global perspective, technical expertise, and policy insight to consulting, where I continue to drive change and advocate for resilient health systems. I am passionate about bridging the gap between innovation and accessibility, empowering LMICs with the tools, policies, and training needed to safeguard public health on a global scale.
-
Independent ConsultantGlobal Laboratory Solutions Llc Oct 2024 - PresentUnited States -
Laboratory And Covid-19 Diagnostics And Testing Specialist (Us Cdc Detailee)The Global Fund Apr 2022 - Sep 2024Geneva, Switzerland -
Health ScientistCenters For Disease Control And Prevention Mar 2018 - Sep 2024Greater Atlanta AreaRetired from US CDC in September 2024 -
Director Strengthening Laboratory Capacity ProgramCenters For Disease Control And Prevention Feb 2012 - Mar 2018ThailandThe Global Disease Detection (GDD) program overarching goal is to provide technical support to rapidly detect, accurately identify, and promptly contain emerging infectious diseases of global public health concern. This capacity building goal is in direct alignment with IHR 2005 requirements. To support this, the Strengthening Laboratory Capacity (SLC) Program has been established. The goals specific to the SLC program are:1. Strengthen partner country laboratory diagnostic capacity and capability to safely and rapidly assess and detect a potential Public Health Emergency of International Concern (PHEIC) in a timely fashion.2. Augment partner country specimen referral and networking system.3. Provide guidance and serve as a resource for partner countries in strategic planning and implementation of laboratory capacity as it pertains to IHR.The main goal of the SLC Program is having our partner countries become IHR 2005 compliant in the area of laboratory capacity. -
Research Microbiologist, Chronic Viral Diseases BranchCenters For Disease Control May 2002 - Feb 2012Head up the genomics research component of the Chronic Fatigue Syndrome molecular epidemiology program. Affymetrix based laboratory with experience in 3' IVT, exon and miRNA arrays. Responsible for analysis of all program studies. experience includes Partek Genomics Suite, Spotfire, BRB ArrayTools, dCHIP, and Bioconductor for array focused algorithms. Ingenuity Pathway Analysis, Pathway Studio and many others used for the biological interpretation of data.Responsible for the implementation of SELDI-TOF mass spectroscopy for exploring the serum proteome of patients with Chronic Fatigue Syndrome. Taken the lead on cellular functional asays which include flow cytometry and ELISA based profiling of serum, plasma and PBMCs.Looking to implement a metabolomic profiling capability. -
Senior Scientific Fellow, Infectious Diseases Pathology ActivityCenters For Disease Control And Prevention Sep 1998 - Mar 2002• Developed an in situ hybridization (ISH) assay against Nipah virus, for both diagnostic and research use. For detection of viral genomic and messenger RNA. This was extended to double label techniques for the co-visualization of protein by IHC and RNA by ISH in tissue sections. In a collaborative project with Cynthia Goldsmith, we took the technology developed for tissue sections and the light microscope and started to adapt the ISH and IHC procedures to electron microscopy. Using biotin or digoxigenin incorporation into riboprobes, two different parameters could be examined on any section by using antibodies to theses ligands that were labeled with different size gold particles. An immuno-label was also developed for detection of viral proteins. These techniques provide a powerful tool to examine viral replication, morphogenesis and pathogenesis at a cellular level.• Developed a TUNEL assay for detection of apoptotic nuclei in tissue sections. • Developed oligonucleotide probes for detection of cytokine and chemokine mRNAs by ISH. -
Staff ScientistPall Corporation Mar 1997 - Aug 1998Developed methodologies for the validation of membrane filters for removal of small (20-25nm) virus particles from blood products using 3 different filtration systems: ultra-, counter flow- and single pass size exclusion filtration. Collaborations with members of the Blood Bank industry (NY) and the Dyax Corporation (Boston) for use of their phage display technology to produce ligands that could irreversibly bind Human Parvovirus B19. Responsible for employing, training, and supervising two technologists, as well as performing a large amount of the work. -
Associate Director/Head Of DepartmentNational Institute For Virology Nov 1994 - Dec 1996• Responsible for establishing a measles virus research laboratory• Oversight of the molecular epidemiological programs for influenza and polio • Development of molecular diagnostic tools for HIV, HCV and rubella virus. • Supervision of departmental staff, both laboratorians and office personnel.• Established collaborations with the Infectious Diseases Hospital at Rietfontein, and township clinics, working very closely with physicians, who helped with specimen collection from patients and case contacts. • Established viral isolation protocols from urine specimens using spin vials. • Instrumental in establishing a sequencing laboratory which moved the Institute from manual to automated sequencing. • Implemented heteroduplex mobility assay for screening the large number of specimens in molecular epidemiology studies. This reduced the number of specimens that were sequenced, saving time and money.• Responsible for departmental administration; supervision of research projects; lecturing and training of university students; grant applications for research funding.
-
National Research Council Post-Doctoral FellowCenters For Disease Control And Prevention Jan 1991 - Sep 1994• Examine the antigenic drift in Influenza B virus isolates. Techniques included RT-PCR, cloning, bacterial manipulation, plasmid preparation, site-directed mutagenesis, and manual DNA sequencing. • Examined the role of defective interfering virus particles in measles virus vaccines and examined cis-acting elements in viral replication. Techniques used included in vitro translation, in vitro transcription, protein expression systems (Vaccinia virus, baculovirus and bacteria), and transient expression systems using calcium phosphate or electroporation for transfection.
Toni Whistler Skills
Toni Whistler Education Details
-
Medical Virology -
Microbiology -
Microbiology -
Chemistry / Microbiology
Frequently Asked Questions about Toni Whistler
What company does Toni Whistler work for?
Toni Whistler works for Global Laboratory Solutions Llc
What is Toni Whistler's role at the current company?
Toni Whistler's current role is Independent Consultant.
What is Toni Whistler's email address?
Toni Whistler's email address is tw****@****cdc.gov
What is Toni Whistler's direct phone number?
Toni Whistler's direct phone number is (404) 639*****
What schools did Toni Whistler attend?
Toni Whistler attended University Of The Witwatersrand, Rhodes University, Rhodes University, Rhodes University.
What are some of Toni Whistler's interests?
Toni Whistler has interest in Proteomics And Genetics.
What skills is Toni Whistler known for?
Toni Whistler has skills like Infectious Diseases, Virology, Molecular Biology, Microbiology, Elisa, Laboratory, Public Health, Epidemiology, Immunology, Biochemistry, Vaccines, Immunohistochemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial